HUP9902417A2 - Alfa-ketoészterek, és alfa-ketoamidok acilezett enol-származékai - Google Patents
Alfa-ketoészterek, és alfa-ketoamidok acilezett enol-származékaiInfo
- Publication number
- HUP9902417A2 HUP9902417A2 HU9902417A HUP9902417A HUP9902417A2 HU P9902417 A2 HUP9902417 A2 HU P9902417A2 HU 9902417 A HU9902417 A HU 9902417A HU P9902417 A HUP9902417 A HU P9902417A HU P9902417 A2 HUP9902417 A2 HU P9902417A2
- Authority
- HU
- Hungary
- Prior art keywords
- alfa
- ketoamides
- ketoesters
- partly
- elastase
- Prior art date
Links
- 150000002085 enols Chemical class 0.000 title 1
- 102000016387 Pancreatic elastase Human genes 0.000 abstract 2
- 108010067372 Pancreatic elastase Proteins 0.000 abstract 2
- 230000002401 inhibitory effect Effects 0.000 abstract 2
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003602 elastase inhibitor Substances 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pulmonology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
A találmány tárgya (I) vagy (IA) általánős képletű alfa-ketőészterekés alfaketőamidők acilezett enőlszármazékai. A találmány szerintivegyületek részint elasztáz inhibitőr hatásúak, részint elasztázinhibitőr hatásúk, részint elasztáz inhibitőrők prődrűgjai, amelyekgyűlladás elleni hatásűk következtében számős kórkép kezelésébenalkalmazhatók. ŕ
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US56619695A | 1995-12-01 | 1995-12-01 |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP9902417A2 true HUP9902417A2 (hu) | 1999-11-29 |
HUP9902417A3 HUP9902417A3 (en) | 2000-11-28 |
Family
ID=24261904
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9902417A HUP9902417A3 (en) | 1995-12-01 | 1996-11-04 | Acylated enol derivatives of alfa-ketoesters and alfa-ketoamides |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP0863915B1 (hu) |
JP (1) | JP2000502073A (hu) |
KR (1) | KR19990071822A (hu) |
CN (1) | CN1127512C (hu) |
AR (1) | AR005240A1 (hu) |
AT (1) | ATE189457T1 (hu) |
AU (1) | AU705819B2 (hu) |
CA (1) | CA2239159C (hu) |
DE (1) | DE69606552T2 (hu) |
ES (1) | ES2144788T3 (hu) |
GR (1) | GR3033205T3 (hu) |
HU (1) | HUP9902417A3 (hu) |
IL (1) | IL124499A (hu) |
MX (1) | MX9804265A (hu) |
NO (1) | NO982467L (hu) |
NZ (1) | NZ322731A (hu) |
PT (1) | PT863915E (hu) |
TW (1) | TW419482B (hu) |
WO (1) | WO1997020856A1 (hu) |
ZA (1) | ZA969889B (hu) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU3359697A (en) * | 1996-07-08 | 1998-02-02 | Yamanouchi Pharmaceutical Co., Ltd. | Bone resorption inhibitors |
DE69824037T2 (de) * | 1997-11-24 | 2005-06-02 | Merck & Co., Inc. | Beta-alanin-derivate als zell-adhäsions-inhibitoren |
US6645939B1 (en) | 1997-11-24 | 2003-11-11 | Merck & Co., Inc. | Substituted β-alanine derivatives as cell adhesion inhibitors |
WO2006113942A2 (en) * | 2005-04-20 | 2006-10-26 | Schering Corporation | Method of inhibiting cathepsin activity |
KR101012313B1 (ko) * | 2008-06-10 | 2011-02-09 | 서울대학교산학협력단 | 염증질환 치료제 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5378457A (en) * | 1981-12-24 | 1995-01-03 | Virogenetics Corporation | Interferon sensitive recombinant poxvirus vaccine |
JPH06504547A (ja) * | 1990-12-28 | 1994-05-26 | ジョージア・テック・リサーチ・コーポレーション | ペプチドケトアミド、ケト酸およびケトエステル |
-
1996
- 1996-11-04 AT AT96939555T patent/ATE189457T1/de not_active IP Right Cessation
- 1996-11-04 CN CN96198733A patent/CN1127512C/zh not_active Expired - Fee Related
- 1996-11-04 HU HU9902417A patent/HUP9902417A3/hu unknown
- 1996-11-04 EP EP96939555A patent/EP0863915B1/en not_active Expired - Lifetime
- 1996-11-04 KR KR1019980704102A patent/KR19990071822A/ko not_active Application Discontinuation
- 1996-11-04 DE DE69606552T patent/DE69606552T2/de not_active Expired - Fee Related
- 1996-11-04 CA CA002239159A patent/CA2239159C/en not_active Expired - Fee Related
- 1996-11-04 AU AU76697/96A patent/AU705819B2/en not_active Ceased
- 1996-11-04 WO PCT/US1996/017752 patent/WO1997020856A1/en not_active Application Discontinuation
- 1996-11-04 ES ES96939555T patent/ES2144788T3/es not_active Expired - Lifetime
- 1996-11-04 PT PT96939555T patent/PT863915E/pt unknown
- 1996-11-04 NZ NZ322731A patent/NZ322731A/en unknown
- 1996-11-04 IL IL12449996A patent/IL124499A/xx not_active IP Right Cessation
- 1996-11-04 JP JP09521265A patent/JP2000502073A/ja active Pending
- 1996-11-25 ZA ZA969889A patent/ZA969889B/xx unknown
- 1996-11-26 TW TW085114600A patent/TW419482B/zh not_active IP Right Cessation
- 1996-11-28 AR ARP960105408A patent/AR005240A1/es not_active Application Discontinuation
-
1998
- 1998-05-28 MX MX9804265A patent/MX9804265A/es unknown
- 1998-05-29 NO NO982467A patent/NO982467L/no not_active Application Discontinuation
-
2000
- 2000-04-12 GR GR20000400899T patent/GR3033205T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2239159A1 (en) | 1997-06-12 |
JP2000502073A (ja) | 2000-02-22 |
TW419482B (en) | 2001-01-21 |
EP0863915A1 (en) | 1998-09-16 |
HUP9902417A3 (en) | 2000-11-28 |
KR19990071822A (ko) | 1999-09-27 |
NO982467D0 (no) | 1998-05-29 |
WO1997020856A1 (en) | 1997-06-12 |
ATE189457T1 (de) | 2000-02-15 |
AU7669796A (en) | 1997-06-27 |
CA2239159C (en) | 2002-09-10 |
ZA969889B (en) | 1997-06-17 |
PT863915E (pt) | 2000-05-31 |
NZ322731A (en) | 1999-10-28 |
IL124499A0 (en) | 1998-12-06 |
AU705819B2 (en) | 1999-06-03 |
EP0863915B1 (en) | 2000-02-02 |
IL124499A (en) | 2003-05-29 |
DE69606552T2 (de) | 2000-09-14 |
MX9804265A (es) | 1998-09-30 |
GR3033205T3 (en) | 2000-08-31 |
ES2144788T3 (es) | 2000-06-16 |
CN1203602A (zh) | 1998-12-30 |
DE69606552D1 (de) | 2000-03-09 |
NO982467L (no) | 1998-08-03 |
CN1127512C (zh) | 2003-11-12 |
AR005240A1 (es) | 1999-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO923280L (no) | Nye oraltvirkende elastaseinhibitorer | |
FI20105844A (fi) | Farmaseuttisia koostumuksia IL-6:n tuoton aiheuttamien sairauksien hoitoon | |
NO965377L (no) | Indolinonforbindelser for behandling av sykdommer | |
NO924461D0 (no) | Dipyridamol for behandling av proliferaktive sykdommer | |
NO20031442L (no) | Morfolin-acetamidderivater for behandling av inflammatoriske sykdommer | |
WO1996023489A3 (de) | Verwendung von carotinoiden zur herstellung von arzneimitteln zur behandlung von dermatosen | |
DE69526183D1 (de) | 3-benzoylphenylessigsäure-derivate enthaltende topische zusammensetzungen zur behandlung der ophthalmischen entzündungserkrankungen | |
NO934218D0 (no) | Inhibitorer av cathepsin G og elastase for forhindring avbindevevsnedbrytning | |
FI935944A0 (fi) | Pyratsolopyrimidin- samt pyrimidinylbisfosfonestrar som anti- inflammatorer | |
DK0869965T3 (da) | Steroidnitritesterderivater anvendelige som antiinflammatoriske lægemidler | |
FI973211A (fi) | Ihmisen leukosyyttielastaasin inhibiittoreina hyödylliset proliinijohdannaiset | |
NO953254D0 (no) | Substituerte azolonderivater for behandling av sykdommer forårsaket av helikobakter | |
AP2000001761A0 (en) | Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase. | |
ATE244712T1 (de) | Piperazino-derivative als neurokininantagonisten | |
ATE203905T1 (de) | Thrombin inhibitor | |
HUP9902417A2 (hu) | Alfa-ketoészterek, és alfa-ketoamidok acilezett enol-származékai | |
NO993627L (no) | Anvendelse av en forbindelse for fremstilling av et legemiddel | |
AP2000001760A0 (en) | Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase. | |
NO934317D0 (no) | Anvendelse av visse metanbisfosfonsyrederivater i brudd-heling | |
NO965099L (no) | Acylerte enolderivater som prolegemidler av elastaseinhibitorer | |
BR9813164A (pt) | Método de uso de inibidores da ciclooxigenase-2 na manutenção do ducto arterial fetal durante o tratamento e prevenção de dores prematuras de parto |